HomeComparePKI vs CAG

PKI vs CAG: Dividend Comparison 2026

PKI yields 0.24% · CAG yields 8.90%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CAG wins by $92.60M in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
CAG
CAG
● Live price
8.90%
Share price
$15.73
Annual div
$1.40
5Y div CAGR
64.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$92.62M
Annual income
$80,567,478.04
Full CAG calculator →

Portfolio growth — PKI vs CAG

📍 CAG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKICAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + CAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
CAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
CAG
Annual income on $10K today (after 15% tax)
$756.52/yr
After 10yr DRIP, annual income (after tax)
$68,482,356.33/yr
At 15% tax rate, CAG beats the other by $68,482,356.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + CAG for your $10,000?

PKI: 50%CAG: 50%
100% CAG50/50100% PKI
Portfolio after 10yr
$46.32M
Annual income
$40,283,739.03/yr
Blended yield
86.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PKI right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
CAG
Analyst Ratings
1
Strong
5
Buy
14
Hold
4
Sell
Consensus: Hold
Price Target
$18.40
+17.0% upside vs current
Range: $15.00 — $22.00
Altman Z
1.5
Piotroski
3/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
CAG buys
0
No recent congressional trades found for PKI or CAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKICAG
Forward yield0.24%8.90%
Annual dividend / share$0.28$1.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%64.8%
Portfolio after 10y$19.7K$92.62M
Annual income after 10y$0.02$80,567,478.04
Total dividends collected$24.00$91.63M
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold
Analyst price target$166.57$18.40

Year-by-year: PKI vs CAG ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrCAG PortfolioCAG Income/yrGap
1← crossover$10,712$12.15$12,167$1,466.75$1.5KCAG
2$11,468$6.08$15,767$2,748.56$4.3KCAG
3$12,274$3.04$22,357$5,485.95$10.1KCAG
4$13,135$1.52$35,902$11,980.72$22.8KCAG
5$14,055$0.76$68,048$29,632.79$54.0KCAG
6$15,039$0.38$159,317$86,504.89$144.3KCAG
7$16,092$0.19$482,399$311,930.56$466.3KCAG
8$17,218$0.10$1,970,880$1,454,712.39$1.95MCAG
9$18,424$0.05$11,262,697$9,153,855.37$11.24MCAG
10$19,713$0.02$92,618,563$80,567,478.04$92.60MCAG

PKI vs CAG: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

CAGConsumer Staples

Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company in North America. The company operates in four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks segment primarily offers shelf stable food products through various retail channels in the United States. The Refrigerated & Frozen segment provides temperature-controlled food products through various retail channels in the United States. The International segment offers food products in various temperature states through retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, including meals, entrees, sauces, and various custom-manufactured culinary products packaged for restaurants and other foodservice establishments in the United States. The company sells its products under the Birds Eye, Duncan Hines, Healthy Choice, Marie Callender's, Reddi-wip, Slim Jim, Angie's BOOMCHICKAPOP, Duke's, Earth Balance, Gardein, and Frontera brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1861 and is headquartered in Chicago, Illinois.

Full CAG Calculator →
📬

Get this PKI vs CAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.